Acompanhe as Notícias da Recifes

The epigenetic modifier MLL4 has an unassuming name—the 4, for instance, indicates it's just one in a family of such modifiers. But MLL4 is quite special: In a specific type of leukemia, it drives disease progression, while in solid tumors, it acts as a suppressor.

A new study led by experts at the University of Nottingham suggests a pet gecko with an unusually high risk of tumors may be a promising model for understanding how cancer develops and spreads. The findings of the study, which are published in BMC Biology, could help explain why

A new therapy offers people with seemingly incurable brain tumors scope for hope: It could slow the progression of the disease and extend patients' lives.

A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive brain cancer. Scientists found that niacin may help revive immune cells that tumors shut down, allowing them to attack cancer more effective

Scientists have long known that heat can be used to help fight cancer. But heating tumors and cancer cells is trickier than it sounds. Apply too much heat and patients could get hurt; apply too little or target the wrong location and the therapy will not be effective.

A naturally occurring bacterium from amphibian intestines completely eliminated colorectal tumors in mice with a single treatment by both attacking cancer cells and activating the immune system. The findings point to a promising new type of cancer therapy that could one day work

This week, researchers reported finding nanoplastics in Antarctic soils for the first time, suggesting they were delivered via long-range atmospheric transport. A study associates the use of hormonal birth control with the risk of brain tumors. And researchers developed a new dru

Researchers found that the common blood pressure drug telmisartan can significantly improve the performance of the cancer drug olaparib, potentially expanding its benefits beyond patients with BRCA-related tumors. The combination is already being tested in human clinical trials a